Literature DB >> 21740807

Campylobacter enteritis in adult patients with acute diarrhea from 2005 to 2009 in Beijing, China.

Jie Chen1, Xin-Ting Sun, Zheng Zeng, Yan-Yan Yu.   

Abstract

BACKGROUND: There has been a marked global increase in the incidence of human Campylobacter enteritis in recent years. This study investigated the epidemiological and clinical features of Campylobacter enteritis in adult patients suffering from acute diarrhea.
METHODS: This was a retrospective review of Campylobacter enteritis in adult patients with acute diarrhea presenting at Beijing University First Hospital, Beijing, China, in the summer and autumn (April to October) of 2005 to 2009. The data collected included the species of campylobacter identified, and the age, gender, clinical manifestations and results of laboratory test on stool samples collected from the patients. Campylobacter sensitivity tests to various antimicrobial agents were conducted on 80 specimens. Chi-square tests were applied using SPSS13.0 software and a two-sided P value of < 0.05 was considered statistically significant.
RESULTS: Campylobacter spp. isolated from the stool specimens of 142 patients with diarrhea represented 14.9% of all the cases examined. C. jejuni was identified in 127 patients (89.4%) and C. coli in 15 others (10.6%). The infection incidence was highest in the age range of 21 - 30 years which comprised 21.7% of the total cases examined. Most cases of diarrhea (46 patients) occurred in June. Watery diarrhea (97.2%), abdominal pain (72.5%) and fever (64.8%) were the most common manifestations of enteric campylobacteriosis. Only four patients (2.8%) had bloody diarrhea. The antimicrobial resistance rates were: cefoperazone (100%), levofloxacin (61.3%), gentamicin (12.5%), erythromycin (6.3%), and azithromycin (2.5%).
CONCLUSIONS: Campylobacter was prevalent among adults with acute diarrhea from 2005 to 2009 in Beijing, China. The large number of those afflicted by the disease warrants the commission of a large multicenter study to determine the extent of enteric campylobacteriosis in this region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740807

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

Review 1.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Investigation of Antimicrobial Susceptibilities and Resistance Genes of Campylobacter Isolates from Patients in Edirne, Turkey.

Authors:  Canan Eryıldız; Nermin Sakru; Gülcan Kuyucuklu
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

3.  Emergence of Genetic Diversity and Multi-Drug Resistant Campylobacter jejuni From Wild Birds in Beijing, China.

Authors:  Juan Du; Jing Luo; Jingjing Huang; Chengmin Wang; Meng Li; Bojun Wang; Bo Wang; Han Chang; Jianwei Ji; Keya Sen; Hongxuan He
Journal:  Front Microbiol       Date:  2019-10-29       Impact factor: 5.640

Review 4.  Human campylobacteriosis: A public health concern of global importance.

Authors:  Aboi Igwaran; Anthony Ifeanyi Okoh
Journal:  Heliyon       Date:  2019-11-14

5.  Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment.

Authors:  Qingqing Xia; Wayne T Muraoka; Zhangqi Shen; Orhan Sahin; Hongning Wang; Zuowei Wu; Peng Liu; Qijing Zhang
Journal:  BMC Microbiol       Date:  2013-06-14       Impact factor: 3.605

6.  Characterization of the virulence, growth temperature and antibiotic resistance of the Campylobacter jejuni IAL 2383 strain isolated from humans.

Authors:  B B Fonseca; D A Rossi; C A Maia; P C Nalevaiko; R T Melo; L P Cuccato; M E Beletti
Journal:  Braz J Microbiol       Date:  2014-05-19       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.